CD4 and neoplasm: Together, these results indicated that CPMV+CPA combination therapy induced the recruitment of innate immune cells in the primary tumor, increased the activation of dendritic cells, and induced tumor‐infiltrating CD4+ and CD8+ T cells to establish adaptive immunity.